Scientific Sessions 2024  /  Late-Breaking Science: In-Depth with VANISH2  /  In-Depth: VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia in Ischemic Cardiomyopathy
Logo

American Heart Association

  113
  0

Final ID:

In-Depth: VANISH2: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia in Ischemic Cardiomyopathy

  • Sapp, John  ( QEII HEALTH SCIENCES CENTRE , Halifax , Nova Scotia , Canada )
    • Author Disclosures:
    John Sapp: DO have relevant financial relationships ; Research Funding (PI or named investigator):Johnson and Johnson:Active (exists now) ; Speaker:Medtronic:Past (completed) ; Speaker:Abbott:Past (completed) ; Consultant:Johnson and Johnson:Past (completed) ; Consultant:Varian:Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Late-Breaking Science: In-Depth with VANISH2

Sunday, 11/17/2024 , 03:30PM - 04:15PM

Late-Breaking Science In-Depth

More abstracts from these authors:
VANISH2 Trial: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

Sapp John

Acceptability and Effectiveness of a Novel, Video-Based CPR and AED Education Program in Canadian Schools

Allan Katherine, Dhillon Santokh, Mcculloch Holly, Ruether Kim, Zotzman Jeanine, Blanchard Ian, Janczyszyn Mike, Wong Natalie, Oneil Emma, Sapp John

You have to be authorized to contact abstract author. Please, Login
Not Available